The drug UKRAIN is being used by more and more physicians in the treatment of various cancers. Due to its wide use in many countries more important clinical information is accumulating all the time.
We have now been informed that a big cytostatics-producing pharmaceutical company wants interfere or even stop the clinical use of UKRAIN. In order to discredit UKRAIN a faked UKRAIN has been brought onto the market. It is highly dubious that this fake contains only alkaloids and looks very similar to UKRAIN but is completely ineffective after administration. The fake is sold for 40 or sometimes 20 euro. This indicates that the motive is not profit but rather the destruction of confidence in UKRAIN.
We are bound in honour to announce this matter.
Vienna, May 12, 2011
German
English